2026-10-28 12:30:00 UTC#528648newconfirmedpress release
Evogene Ltd. stock news
Evogene Ltd. stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire17 wire items
2026-10-06 20:18:28 UTC#421920duplicateconfirmednews
Evogene Ltd. board reconstituted with Itay Maroz and Shahar Zadok replacing Dan Falk and Adrian Percy
2026-10-06 20:18:00 UTC#421922duplicateconfirmednews
Evogene and Pure Capital Group finalize board reconstitution agreement
2026-10-06 20:00:00 UTC#421763newconfirmednews
Evogene reaches cooperation agreement with Pure Capital Group to reconstitute board of directors
2026-09-30 11:25:44 UTC#390898newconfirmednews
Evogene granted 180-day extension by Nasdaq to regain minimum bid price compliance
2026-09-28 20:29:38 UTC#380127newconfirmeddata release
Evogene reports GAAP EPS of -$0.63 and revenue of $0.68M
2026-08-31 12:00:00 UTC#242343newconfirmedpress release
Evogene urges shareholders to reject dissident board nominees ahead of September 4 annual meeting
2026-08-25 11:00:00 UTC#216943newconfirmedpress release
ISS and Glass Lewis recommend Evogene shareholders vote for company board nominees at September 4 meeting
pr_newswireimportance 0.40trust 0.90Evogene Ltd. +0.40Institutional Shareholder Services Inc. +0.30Glass Lewis & Co., LLC +0.30+1 entities
2026-08-18 12:04:00 UTC#189397duplicateconfirmedpress release
Evogene Ltd. Reports Q2 2026 Net Loss of $1.8M, Down from $4.7M YoY; Cash Burn Forecast at $8.5M-$9.5M for 2026
2026-08-18 11:06:34 UTC#189131newconfirmednews
Evogene Q2 GAAP EPS -$0.13 beats by $0.14, Revenue $0.35M beats by $0.02M
2026-08-17 17:46:33 UTC#185982newforecastanalysis
Evogene Ltd. Q2 2026 Earnings Preview
2026-08-14 13:07:05 UTC#178139newforecastnews
Evogene Ltd. (EVGN) Q2 2026 earnings preview: analysts expect $0.27 loss per share and $325K revenue
2026-08-14 11:00:00 UTC#177455newconfirmedpress release
Evogene Chairman Nir Nimrodi to address dissident shareholder situation during August 18 earnings call
2026-08-11 11:00:17 UTC#158293newforecastnews
Evogene Ltd. (EVGN) Q2 2026 Earnings Preview: Revenue Estimate $325K, EPS Loss $0.27
2026-07-22 12:00:00 UTC#62731newconfirmedpress release
Evogene and ELEO partner to develop oral small-molecule PCSK9 inhibitors for cardiovascular disease
2026-07-10 13:36:01 UTC#20118newconfirmednews
Kfir Silberman Discloses 12.61% Stake in Evogene, Seeks Board Overhaul
tradingviewimportance 0.50trust 0.80Evogene Ltd. -0.30Kfir Silberman +0.30L.I.A. Pure Capital Ltd. +0.30+1 entities
2026-07-08 11:00:00 UTC#11870newconfirmedpress release
Evogene and Tel Aviv University's BCDD Launch AI Drug Discovery Initiative
pr_newswireimportance 0.40trust 0.90Evogene Ltd. +0.40Blavatnik Center for Drug Discovery +0.40Tel Aviv University +0.30+2 entities